{"id":49633,"date":"2025-09-24T18:08:02","date_gmt":"2025-09-24T12:38:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=49633"},"modified":"2025-09-24T18:08:28","modified_gmt":"2025-09-24T12:38:28","slug":"check-aptus-pharma-ipo-subscription-day-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/check-aptus-pharma-ipo-subscription-day-2\/","title":{"rendered":"Check Aptus Pharma IPO Subscription Day 2"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click and Sign Up to Get Latest Updates on Aptus Pharma IPO&nbsp;<\/em><\/strong><\/a><\/p><p>Here, the Aptus Pharma IPO launched on 23rd September 2025. The issue will be closed for bidding today, on 25th September 2025. The primary aim of the <strong>Aptus Pharma IPO <\/strong>is to raise \u20b913.02 crores from the market. Additionally, the Aptus Pharma IPO has received an impressive level of subscription, which suggests that the shares will be listed at a remarkable premium. Scroll down to check the Aptus Pharma IPO subscription and details.&nbsp;<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/check-aptus-pharma-ipo-subscription-day-2\/#Aptus_Pharma_IPO_Details\" title=\"Aptus Pharma IPO Details&nbsp;\">Aptus Pharma IPO Details&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/check-aptus-pharma-ipo-subscription-day-2\/#Aptus_Pharma_IPO_Subscription_Status\" title=\"Aptus Pharma IPO Subscription Status\">Aptus Pharma IPO Subscription Status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/check-aptus-pharma-ipo-subscription-day-2\/#About_Aptus_Pharma_Limited\" title=\"About Aptus Pharma Limited\">About Aptus Pharma Limited<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/check-aptus-pharma-ipo-subscription-day-2\/#Technical_Indicators\" title=\"Technical Indicators\">Technical Indicators<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/check-aptus-pharma-ipo-subscription-day-2\/#Aptus_Pharma_IPO_Listing_Expectations\" title=\"Aptus Pharma IPO Listing Expectations\">Aptus Pharma IPO Listing Expectations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/check-aptus-pharma-ipo-subscription-day-2\/#Aptus_Pharma_IPO_GMP_Today\" title=\"Aptus Pharma IPO GMP Today\">Aptus Pharma IPO GMP Today<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/check-aptus-pharma-ipo-subscription-day-2\/#Aptus_Pharma_IPO_Dates\" title=\"Aptus Pharma IPO Dates\">Aptus Pharma IPO Dates<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/check-aptus-pharma-ipo-subscription-day-2\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Details\"><\/span><strong>Aptus Pharma IPO Details&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>23rd September 2025<\/td><\/tr><tr><td><strong>Face Value&nbsp;<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Price Band<\/strong><\/td><td>\u20b965 to \u20b970 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>2,000 Shares<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE &amp; SME<\/td><\/tr><tr><td><strong>IPO Close Date&nbsp;<\/strong><\/td><td>25th September 2025<\/td><\/tr><tr><td><strong>Listing Date&nbsp;<\/strong><\/td><td>30th September 2025<\/td><\/tr><\/tbody><\/table><\/figure><p>The price band for the Aptus Pharma IPO has been prescribed as \u20b965 to \u20b970 per share, with a total of 18,60,000 shares to be issued. Let&#8217;s segregate the share quota fixed for different categories of investors.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Categories<\/strong><\/td><td><strong>Shares Offered<\/strong><\/td><td><strong>% Shares offered<\/strong><\/td><\/tr><tr><td><strong>Market Maker Shares Offered<\/strong><\/td><td>94,000<\/td><td>5.05%<\/td><\/tr><tr><td><strong>QIB Shares Offered<\/strong><\/td><td>8,80,000<\/td><td>47.31%<\/td><\/tr><tr><td><strong>NII (HNI) Shares Offered<\/strong><\/td><td>2,66,000<\/td><td>14.30%<\/td><\/tr><tr><td><strong>Retail Investors<\/strong><\/td><td>6,20,000<\/td><td>33.33%<\/td><\/tr><tr><td><strong>Total Shares Offered<\/strong><\/td><td>18,60,000<\/td><td>100.00%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Subscription_Status\"><\/span><strong>Aptus Pharma IPO Subscription Status<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of now, the Aptus Pharma IPO has been subscribed to 3.17 times. Of these, 3.99 times are subscribed by retail investors, 5.47 times by non-institutional investors, and 0.00 times by QII (Qualified Institutional Investors).&nbsp;&nbsp;<\/p><p>The healthy subscription status indicates that investors are expecting higher returns at the time of the Aptus Pharma IPO listing on 30th September 2025. Aptus Pharma also has a positive outlook behind the fresh issue of 0.19 crore shares, which is expected to raise around Rs 13.02 crore.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Aptus_Pharma_Limited\"><\/span><strong>About Aptus Pharma Limited<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. The company manufactures and distributes a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids &amp; PPIs, pain management, anti-inflammatories, antibiotics, cardiology &amp; antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Technical_Indicators\"><\/span><strong>Technical Indicators<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Several technical indicators are available to assess a company&#8217;s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of <strong>Aptus Pharma Limited.<\/strong><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)<\/strong><\/a><strong>&nbsp;<\/strong><\/td><td>11.29<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>6.20<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-capital-employed\"><strong>ROCE<\/strong><\/a><\/td><td>45.66%<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-equity\"><strong>ROE<\/strong><\/a><\/td><td>44.50%<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>44.50%<\/td><\/tr><tr><td><strong>PAT Margin<\/strong><\/td><td>&#8211;<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>19.31%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>&#8211;<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b948.02 Cr<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Listing_Expectations\"><\/span><strong>Aptus Pharma IPO Listing Expectations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The Aptus Pharma IPO allotment is still pending. However, according to current GMP or market sentiments, it is reasonable to expect higher listing gains from the share. A 10.00% jump in Aptus Pharma IPO GMP indicates that the estimated listing price per share will be approximately Rs 7.<\/p><p>It will provide higher listing gains to investors who applied for this IPO. Additionally, the financial fundamentals of this business made it the experts&#8217; top long-term recommendation.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_GMP_Today\"><\/span><strong>Aptus Pharma IPO GMP Today<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>We know that higher subscription prices encourage grey market premiums for IPOs. Let\u2019s explore the Aptus Pharma IPO GMP for 24th September 2025.&nbsp;<\/p><p>The grey market premium for this IPO is 10.00%, or Rs 7 per share. It indicates that the estimated listing price per share is Rs 77. Numerous factors played a pivotal role in this jump in the Aptus Pharma IPO GMP. These include higher subscription rates received, positive market sentiments, and investors&#8217; positive attitude towards IPOs.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP Date<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP<\/strong><\/td><td><strong>Estimated Listing Price&nbsp;<\/strong><\/td><td><strong>Estimated Listing Gains<\/strong><\/td><\/tr><tr><td><strong>24-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>23-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>22-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>21-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>20-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>19-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>18-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b90.00<\/td><td>\u20b972.00&nbsp;<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Dates\"><\/span><strong>Aptus Pharma IPO Dates<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>23rd September 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>25th September 2025<\/td><\/tr><tr><td><strong>Allotment<\/strong><\/td><td>26th September 2025<\/td><\/tr><tr><td><strong>Refund Date<\/strong><\/td><td>29th September 2025<\/td><\/tr><tr><td><strong>IPO Listing Date<\/strong><\/td><td>30th September 2025<\/td><\/tr><\/tbody><\/table><\/figure><p><strong>Note<\/strong>: IPO GMP is highly volatile, influenced by market sentiment. Hence, one should conduct their research before investing in it.<\/p><p><strong><em>Download <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/top-10-penny-stocks-in-india\">Top 10 Penny Stocks in India | Penny Stocks to Buy in 2025<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/best-stocks-to-buy-today-6\">Best Stocks to Buy Today: Explore Best Stocks With Expected Trends<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/milky-mist-dairy-foods-ipo-details\">Milky Mist Dairy Foods IPO Details: Everything You Should Know about<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/karbonsteel-engineering-ipo-gmp-review\">Karbonsteel Engineering IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/taurian-mps-ipo-gmp-review\">Taurian MPS IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/shringar-house-of-mangalsutra-ipo-gmp-review\">Shringar House of Mangalsutra IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/dev-accelerator-ipo-gmp-review\">Dev Accelerator IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/vigor-plast-india-ipo-listing-preview\">Vigor Plast India IPO Listing Preview: What to Expect Now?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/krupalu-metals-ipo-gmp-live-updates-2\">Krupalu Metals IPO GMP: Day 3 IPO Live Updates<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click and Sign Up to Get Latest Updates on Aptus Pharma IPO&nbsp; Here, the Aptus Pharma IPO launched on 23rd September 2025. The issue will be closed for bidding today, on 25th September 2025. The primary aim of the Aptus Pharma IPO is to raise \u20b913.02 crores from the market. Additionally, the Aptus Pharma IPO<\/p>\n","protected":false},"author":23,"featured_media":49634,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[2304],"class_list":["post-49633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-aptus-pharma-ipo"],"metadata":{"_edit_lock":["1758717508:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_seo_score":["81"],"rank_math_primary_category":["1281"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"rank_math_title":["Aptus Pharma IPO Subscription Status Day 2: Check Online "],"rank_math_description":["Check the Aptus Pharma IPO subscription status online and also get live GMP details and reviews to anticipate the listing gains. Explore for more information about the Aptus Pharma IPO. \r\n"],"rank_math_focus_keyword":["Aptus Pharma IPO"],"_thumbnail_id":["49634"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["3394"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/check-aptus-pharma-ipo-subscription-day-2"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/09\/24175907\/Aptus-Pharma-IPO-Subscription-Day-2.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/49633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=49633"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/49633\/revisions"}],"predecessor-version":[{"id":49635,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/49633\/revisions\/49635"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/49634"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=49633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=49633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=49633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}